Euroscan International Network, National Institute for Health Research (NIHR), Agency for Healthcare Research and Quality (AHRQ) and Haute Autorité de Santé (HAS) from 2006 to 2017. Title, abstract and full text screening were performed by two independent reviewers relying on prespecifed eligibility criteria. Critical appraisal of literature was conducted using INAHTA and PRISMA checklists, FLC 2.0 and The European Network for HTA (EUnetHTA) adaptation toolkit. One review from AHRQ was retained. An adaptation process has been launched. Data on lipid lowering agents intake from key institutions have been gathered and a qualitative study has been started through interviews with thirty-three cardiologists and general practitioners from public, private sector and scientifc societies. Interviews have been analysed using NVivo. After results discussion with the working group, the report will be synthesized and validated. RESULTS: According to the AHRQ report, all evidence for clinical outcomes were graded insufcient when comparing the therapies. Results on lowering low density lipoprotein (LDL-C) depend on the combination agent Ezetimibe has shown remarkable results (3). The Tunisian context shows that there is no standardized method to assess the cardiovascular risk according to the preliminary results. The only combination therapy reported is with fbrates, mainly in case of associated hypertriglyceridemia. Ezetimibe has not yet obtained the marketing authorization. CONCLUSIONS: There are signifcant diferences between contexts and among practitioners prescriptions. This can be related to the lack of common guidelines and inequitable access to drugs and healthcare resources in general. REFERENCES: 1. Critchley J, Capewell S, O ’Flaherty M, et al. Contrasting cardiovascular mortality trends in Eastern Mediterranean populations: contributions from risk factor changes and treatments. Int J Cardiol. 2016 1;208:150-61. 2. Tunisia. National insurance fund [Internet] 2015. [Cited 30 November 2016]. Available from: https//www.cnam.nat.tn 3. Monroe AK, Gudzune KA, Sharma R, et al. Combination therapy versus intensifcation of statin monotherapy: an update. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Feb. Report No.: 14-EHC013-EF. ................................................................................... PP170 Health Impact Assessment Of Teleradiology Programs In Disadvantaged Areas AUTHORS: Ottavio Davini (ottavio.davini@gmail.com), Giovanni Digiacomo, Matteo Perusia, Valeria Romano, Chiara Rivoiro, Rosario Servetto, Marika Giacometti, Marco Glisoni, Maria Rosaria Gualano, Roberta Siliquini, Marco Grosso INTRODUCTION: Within the Home Radiology service of the Piedmont Region - R@dhome (1) - it was decided to employ a mobile radiological service to allow minor radiological procedures to be conducted in rural areas. Cortemilia (average age of population 51.6 years, population over 65 years 33.6 percent) is situated in Piedmont (Langhe region) and it is about 40 kilometers, with bad roads, from the nearest hospital. For this reason it’s important to optimize the potential ofered by telemedicine. The purpose of R@dhome is to provide simple radiological services (ambulatory) to vulnerable patients in outpatient settings. The aim of this work was to implement an assessment, based on Health Impact Analysis (HIA) (2,3) criteria, of the health intervention provided by the R@dhome service. METHODS: From January 2016 to December 2016 the following were assessed:  number of patients examined in the local radiological ambulatory service ................................................................................................................................................................................... 144 POSTER PRESENTATIONS https://doi.org/10.1017/S0266462317002987 Downloaded from https://www.cambridge.org/core. IP address: 207.241.231.80, on 25 Jul 2018 at 08:43:23, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.